Giftan 50mg Tablet

Giftan 50mg Tablet (Advanced Angiotensin II Receptor Antagonist & Vascular Protection Matrix)

Giftan 50mg Tablet is a prescription-grade, high-potency cardiovascular and renal protective intervention containing pure Losartan Potassium. Formulated for the clinical and clinical lifestyle management of systemic arterial hypertension, chronic vascular tension, left ventricular myocardial hypertrophy, and diabetic nephropathy, this product acts as a highly selective, non-peptide Angiotensin II receptor blocker (ARB). It works by executing a targeted molecular blockade at the AT$_1$ receptor subtype site, preventing the binding of endogenous angiotensin II—a potent systemic vasoconstrictor. By effectively neutralizing angiotensin II-mediated arterial constriction, aldosterone secretion, and renal sodium retention loops, Giftan 50mg induces significant vascular smooth muscle relaxation. This targeted action drops systemic peripheral resistance, lowers baseline blood pressure, improves cardiac output parameters, and reduces long-term physical workloads on the heart walls. Concurrently, it reduces renal intraglomerular pressure patterns, executing an advanced microvascular safeguard that slows down the structural progression of kidney tissue exhaustion in diabetic individuals presenting with macro-albuminuria.

Key Features

• Selectively binds to angiotensin II receptor sites, blocking arterial narrowing signals and promoting natural vascular smooth muscle relaxation to drop systemic blood pressure.
• Clinically recognized for its capability to reduce the long-term risk of cerebrovascular accidents (stroke) and progressive left ventricular thickening in hypertensive patient profiles.
• Significantly drops microvascular pressure within the kidneys, slowing down chronic renal decline and managing protein leakage parameters in Type 2 diabetic individuals.
• Powered by its highly active, long-lasting carboxylic acid metabolite to provide consistent, continuous blood pressure regulation across full day-and-night cycles with a single daily dose.
• Designed to regulate blood pressure parameters without accumulating systemic bradykinin, significantly reducing the risks of chronic dry cough associated with standard ACE-inhibitor classes.

Key Ingredients

• Losartan Potassium (50mg)
• Calibrated Pharmaceutical-Grade Excipients

How to Use

• This is a highly active, prescription-only pharmaceutical intervention. Initiating, tracking, or altering the deployment sequence must be executed strictly under the authorization of a registered medical specialist.
• Consume one tablet (50mg) once daily, or follow the precise, calibrated strength modifications (ranging from 25mg to 100mg) as mapped out based on your individual physiological response curves.
• Swallow the tablet whole with a full glass of clear water.
• Maintain the administrative sequence daily without interruption, even if external symptomatic parameters normalize, to guarantee continuous, stable molecular protection of the heart and kidneys.
• Pair the routine with periodic home arterial blood pressure logs and scheduled laboratory blood filtration profiles to document accurate therapeutic tracking parameters.

Precautions

• Do not use during pregnancy. Exposure to angiotensin receptor blockers during the second and third trimesters can induce severe fetal injury, renal failure, and neonatal mortality loops. Discontinue the drug immediately upon confirmation of pregnancy.
• Individuals presenting with severe pre-existing renal artery stenosis, severe volume depletion (due to high-dose diuretic therapies, severe vomiting, or diarrhea) must be carefully rehydrated prior to initiation to prevent acute hypotensive episodes.
• This intervention can reduce aldosterone secretion, leading to localized potassium retention. Avoid utilizing potassium-containing mineral supplements or low-sodium salt alternatives containing potassium chloride without explicit specialist approval.
• Individuals presenting with a clinical history of significant hepatic impairment or cirrhosis may clear the drug slower, requiring low-dose initiation patterns (e.g., 25mg daily) under direct medical supervision.
• Discontinue use immediately and seek urgent emergency medical attention if you manifest signs of acute angioedema, including sudden swelling of the face, lips, tongue, or localized upper respiratory tract mucosa.
• Keep the blister strips tightly sealed within their original container. Store in a cool, dry repository below 30°C (away from high moisture zones, humidity infiltration, and direct sunlight exposures) to preserve complete molecular structural integrity.

Warning

• This tablet is engineered solely for oral gastrointestinal absorption; do not attempt to crush or dissolve the active matrix for unauthorized topical or alternative experimental entry pathways.
• Do not abruptly halt the daily administration sequence without explicit specialist consultation; doing so can cause a rapid rebound to high baseline arterial blood pressure, stressing the cardiac muscles.
• This product may induce mild, transient dizziness or lightheadedness, especially during the initial initiation or dosage escalation phases. Avoid operating heavy machinery or driving vehicles until your physiological accommodation parameters are verified.
• Verify that the outer carton seals, batch codes, manufacturing credentials, and the internal aluminum foil barrier’s structural integrity are fully uncompromised before dispensing.

Legal Disclaimer: Giftan 50mg Tablet is a prescription pharmaceutical drug. Individual clinical outcomes, blood pressure stabilization curves, and long-term organ protection parameters vary based on baseline health profiles, comorbidities, and complete compliance with professional medical guidance. This information is for educational purposes and is not a substitute for formal, direct clinical diagnosis, medical advice, or independent prescription treatment plans from a qualified healthcare practitioner.